This report aims to provide a comprehensive presentation of the global market for 3D Printing Drug Formulation and Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Drug Formulation and Administration. This report contains market size and forecasts of 3D Printing Drug Formulation and Administration in global, including the following market information:
Global 3D Printing Drug Formulation and Administration Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global 3D Printing Drug Formulation and Administration market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
MED Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of 3D Printing Drug Formulation and Administration include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Merck KgaA, GlaxoSmithKline, Pfizer and Craft Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the 3D Printing Drug Formulation and Administration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 3D Printing Drug Formulation and Administration Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, by Type, 2022 (%)
MED
FDM
SSE
Other
Global 3D Printing Drug Formulation and Administration Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, by Application, 2022 (%)
Drugs
Dietary Supplement
Global 3D Printing Drug Formulation and Administration Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global 3D Printing Drug Formulation and Administration Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 3D Printing Drug Formulation and Administration revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies 3D Printing Drug Formulation and Administration revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of 3D Printing Drug Formulation and Administration, market overview.
Chapter 2: Global 3D Printing Drug Formulation and Administration market size in revenue.
Chapter 3: Detailed analysis of 3D Printing Drug Formulation and Administration company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 3D Printing Drug Formulation and Administration in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 3D Printing Drug Formulation and Administration Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 3D Printing Drug Formulation and Administration Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global 3D Printing Drug Formulation and Administration Overall Market Size
2.1 Global 3D Printing Drug Formulation and Administration Market Size: 2022 VS 2029
2.2 Global 3D Printing Drug Formulation and Administration Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top 3D Printing Drug Formulation and Administration Players in Global Market
3.2 Top Global 3D Printing Drug Formulation and Administration Companies Ranked by Revenue
3.3 Global 3D Printing Drug Formulation and Administration Revenue by Companies
3.4 Top 3 and Top 5 3D Printing Drug Formulation and Administration Companies in Global Market, by Revenue in 2022
3.5 Global Companies 3D Printing Drug Formulation and Administration Product Type
3.6 Tier 1, Tier 2 and Tier 3 3D Printing Drug Formulation and Administration Players in Global Market
3.6.1 List of Global Tier 1 3D Printing Drug Formulation and Administration Companies
3.6.2 List of Global Tier 2 and Tier 3 3D Printing Drug Formulation and Administration Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global 3D Printing Drug Formulation and Administration Market Size Markets, 2022 & 2029
4.1.2 MED
4.1.3 FDM
4.1.4 SSE
4.1.5 Other
4.2 By Type - Global 3D Printing Drug Formulation and Administration Revenue & Forecasts
4.2.1 By Type - Global 3D Printing Drug Formulation and Administration Revenue, 2018-2023
4.2.2 By Type - Global 3D Printing Drug Formulation and Administration Revenue, 2024-2029
4.2.3 By Type - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global 3D Printing Drug Formulation and Administration Market Size, 2022 & 2029
5.1.2 Drugs
5.1.3 Dietary Supplement
5.2 By Application - Global 3D Printing Drug Formulation and Administration Revenue & Forecasts
5.2.1 By Application - Global 3D Printing Drug Formulation and Administration Revenue, 2018-2023
5.2.2 By Application - Global 3D Printing Drug Formulation and Administration Revenue, 2024-2029
5.2.3 By Application - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global 3D Printing Drug Formulation and Administration Market Size, 2022 & 2029
6.2 By Region - Global 3D Printing Drug Formulation and Administration Revenue & Forecasts
6.2.1 By Region - Global 3D Printing Drug Formulation and Administration Revenue, 2018-2023
6.2.2 By Region - Global 3D Printing Drug Formulation and Administration Revenue, 2024-2029
6.2.3 By Region - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America 3D Printing Drug Formulation and Administration Revenue, 2018-2029
6.3.2 US 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.3.3 Canada 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.3.4 Mexico 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe 3D Printing Drug Formulation and Administration Revenue, 2018-2029
6.4.2 Germany 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.3 France 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.4 U.K. 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.5 Italy 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.6 Russia 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.7 Nordic Countries 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.4.8 Benelux 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia 3D Printing Drug Formulation and Administration Revenue, 2018-2029
6.5.2 China 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.5.3 Japan 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.5.4 South Korea 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.5.5 Southeast Asia 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.5.6 India 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America 3D Printing Drug Formulation and Administration Revenue, 2018-2029
6.6.2 Brazil 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.6.3 Argentina 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa 3D Printing Drug Formulation and Administration Revenue, 2018-2029
6.7.2 Turkey 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.7.3 Israel 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.7.4 Saudi Arabia 3D Printing Drug Formulation and Administration Market Size, 2018-2029
6.7.5 UAE 3D Printing Drug Formulation and Administration Market Size, 2018-2029
7 3D Printing Drug Formulation and Administration Companies Profiles
7.1 Aprecia Pharmaceuticals
7.1.1 Aprecia Pharmaceuticals Company Summary
7.1.2 Aprecia Pharmaceuticals Business Overview
7.1.3 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Major Product Offerings
7.1.4 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.1.5 Aprecia Pharmaceuticals Key News & Latest Developments
7.2 Triastek
7.2.1 Triastek Company Summary
7.2.2 Triastek Business Overview
7.2.3 Triastek 3D Printing Drug Formulation and Administration Major Product Offerings
7.2.4 Triastek 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.2.5 Triastek Key News & Latest Developments
7.3 FabRx
7.3.1 FabRx Company Summary
7.3.2 FabRx Business Overview
7.3.3 FabRx 3D Printing Drug Formulation and Administration Major Product Offerings
7.3.4 FabRx 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.3.5 FabRx Key News & Latest Developments
7.4 Multiply Labs
7.4.1 Multiply Labs Company Summary
7.4.2 Multiply Labs Business Overview
7.4.3 Multiply Labs 3D Printing Drug Formulation and Administration Major Product Offerings
7.4.4 Multiply Labs 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.4.5 Multiply Labs Key News & Latest Developments
7.5 Merck KgaA
7.5.1 Merck KgaA Company Summary
7.5.2 Merck KgaA Business Overview
7.5.3 Merck KgaA 3D Printing Drug Formulation and Administration Major Product Offerings
7.5.4 Merck KgaA 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.5.5 Merck KgaA Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline 3D Printing Drug Formulation and Administration Major Product Offerings
7.6.4 GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer 3D Printing Drug Formulation and Administration Major Product Offerings
7.7.4 Pfizer 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Craft Health
7.8.1 Craft Health Company Summary
7.8.2 Craft Health Business Overview
7.8.3 Craft Health 3D Printing Drug Formulation and Administration Major Product Offerings
7.8.4 Craft Health 3D Printing Drug Formulation and Administration Revenue in Global Market (2018-2023)
7.8.5 Craft Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. 3D Printing Drug Formulation and Administration Market Opportunities & Trends in Global Market
Table 2. 3D Printing Drug Formulation and Administration Market Drivers in Global Market
Table 3. 3D Printing Drug Formulation and Administration Market Restraints in Global Market
Table 4. Key Players of 3D Printing Drug Formulation and Administration in Global Market
Table 5. Top 3D Printing Drug Formulation and Administration Players in Global Market, Ranking by Revenue (2022)
Table 6. Global 3D Printing Drug Formulation and Administration Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global 3D Printing Drug Formulation and Administration Revenue Share by Companies, 2018-2023
Table 8. Global Companies 3D Printing Drug Formulation and Administration Product Type
Table 9. List of Global Tier 1 3D Printing Drug Formulation and Administration Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 3D Printing Drug Formulation and Administration Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - 3D Printing Drug Formulation and Administration Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - 3D Printing Drug Formulation and Administration Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - 3D Printing Drug Formulation and Administration Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - 3D Printing Drug Formulation and Administration Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global 3D Printing Drug Formulation and Administration Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global 3D Printing Drug Formulation and Administration Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2024-2029
Table 30. Aprecia Pharmaceuticals Company Summary
Table 31. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product Offerings
Table 32. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 33. Aprecia Pharmaceuticals Key News & Latest Developments
Table 34. Triastek Company Summary
Table 35. Triastek 3D Printing Drug Formulation and Administration Product Offerings
Table 36. Triastek 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 37. Triastek Key News & Latest Developments
Table 38. FabRx Company Summary
Table 39. FabRx 3D Printing Drug Formulation and Administration Product Offerings
Table 40. FabRx 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 41. FabRx Key News & Latest Developments
Table 42. Multiply Labs Company Summary
Table 43. Multiply Labs 3D Printing Drug Formulation and Administration Product Offerings
Table 44. Multiply Labs 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 45. Multiply Labs Key News & Latest Developments
Table 46. Merck KgaA Company Summary
Table 47. Merck KgaA 3D Printing Drug Formulation and Administration Product Offerings
Table 48. Merck KgaA 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 49. Merck KgaA Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline 3D Printing Drug Formulation and Administration Product Offerings
Table 52. GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer 3D Printing Drug Formulation and Administration Product Offerings
Table 56. Pfizer 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Craft Health Company Summary
Table 59. Craft Health 3D Printing Drug Formulation and Administration Product Offerings
Table 60. Craft Health 3D Printing Drug Formulation and Administration Revenue (US$, Mn) & (2018-2023)
Table 61. Craft Health Key News & Latest Developments
List of Figures
Figure 1. 3D Printing Drug Formulation and Administration Segment by Type in 2022
Figure 2. 3D Printing Drug Formulation and Administration Segment by Application in 2022
Figure 3. Global 3D Printing Drug Formulation and Administration Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global 3D Printing Drug Formulation and Administration Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global 3D Printing Drug Formulation and Administration Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by 3D Printing Drug Formulation and Administration Revenue in 2022
Figure 8. By Type - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 9. By Application - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 10. By Type - Global 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 12. By Application - Global 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 14. By Region - Global 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 15. By Country - North America 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 16. US 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 17. Canada 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 20. Germany 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 21. France 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 23. Italy 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 24. Russia 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 28. China 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 29. Japan 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 32. India 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 34. Brazil 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa 3D Printing Drug Formulation and Administration Revenue Market Share, 2018-2029
Figure 37. Turkey 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 38. Israel 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 40. UAE 3D Printing Drug Formulation and Administration Revenue, (US$, Mn), 2018-2029
Figure 41. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Triastek 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. FabRx 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Multiply Labs 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck KgaA 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Craft Health 3D Printing Drug Formulation and Administration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
